Examining the Effect of Piano Playing Training on Fine Motor Skills in Parkinson's Patients

Sponsor
Tel Aviv University (Other)
Overall Status
Suspended
CT.gov ID
NCT06120192
Collaborator
Sheba Medical Center (Other)
3
1
1
28.3
0.1

Study Details

Study Description

Brief Summary

Piano playing may provide an engaging and accessible setting for finger and wrist movement training. Moreover, it has been found effective for improving manual dexterity and upper-limb function in other neurologic disorders, such as stroke and additionally beneficial for cognitive and psychosocial support in Parkinson's disease. However, no study has examined the effect of piano playing on dexterity in Parkinson's disease. The aim of this study is to test the efficacy of a novel piano-based training program on fine motor function in patients with PD. Participants with Parkinson's disease will take part in an individually tailored 6-week piano training program, combining weekly supervised training sessions (6x60 min altogether), with three independent at-home weekly 30 minutes practice sessions (18x30 altogether). Participants will receive a piano MIDI keyboard for home use during the study.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Piano
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
3 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Open label feasibility studyOpen label feasibility study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Examining the Effect of Piano Playing Training on Fine Motor Skills in Parkinson's Patients
Actual Study Start Date :
Aug 22, 2022
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Research group

Receives the full piano training

Behavioral: Piano
Receives the piano training

Outcome Measures

Primary Outcome Measures

  1. Box and block test [First meeting, last meeting (after 6 weeks)]

    Number of blocks that can be moved over a barrier using the hand / arm in one minute

  2. 9 Hole peg test [First meeting, last meeting (after 6 weeks)]

    Time taken to insert 9 pegs into holes and then remove them

  3. Synergy index [First meeting, last meeting (after 6 weeks)]

    Calculated from a force ramp production task using the fingers with force sensors

  4. Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) motor parts II (patient questionnaire) - parts 2.4 to 2.7 and III (motor examination) - parts 3.3 and 3.4 [First meeting, last meeting (after 6 weeks)]

    Standard questionnaire used in Parkinson's disease. Higher scores indicate more impairment. Maximum score for each part is 4, so overall for the 6 parts the maximum score is 24.

Secondary Outcome Measures

  1. Quantitative Digitography - Average strike duration [First meeting, last meeting (after 6 weeks)]

    Measure of speed and variability of key presses on a piano - mean of the time the key is pressed

  2. Quantitative Digitography - Coefficient of variation strike duration [First meeting, last meeting (after 6 weeks)]

    Measure of speed and variability of key presses on a piano - coefficient of variation of the time the key is pressed

  3. Quantitative Digitography - Average interval between strikes (in seconds) [First meeting, last meeting (after 6 weeks)]

    Measure of speed and variability of key presses on a piano - average time between subsequent key presses

  4. Quantitative Digitography - Coefficient of variation of interval between strikes [First meeting, last meeting (after 6 weeks)]

    Measure of speed and variability of key presses on a piano - coefficient of variation of the time between subsequent key presses

  5. Quantitative assessment of piano performance progress [First meeting, last meeting (after 6 weeks)]

    Measurement of improvement in playing the piano - the teacher (rater) will give a score (between 0 and 5) for the level of piano playing of the participant, where 0 is no ability to play and 5 is the ability to play the pieces from the workbook (a beginner's level piano book) perfectly.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Idiopathic Parkinson's Disease patients

  • Hoehn and Yahr stages I to III

  • Self-reports of some dexterity difficulties

Exclusion Criteria:
  • Participation in an ongoing clinical study or clinical study within 30 days prior to this study

  • Atypical parkinsonian syndrome or secondary parkinsonism (e.g., due to drugs, metabolic neurogenetic disorders, encephalitis, cerebrovascular disease, or other degenerative disease), or other neurologic conditions influencing upper limb movement

  • Significant psychiatric symptoms or history

  • Significant or recent experience in piano playing (participants who are proficient piano players, or had studied piano for more than 3 years in the past, or for shorter periods in the last 5 years)

  • Other significant fine motor skills (e.g., high proficiency in playing another musical instrument, video games, etc.)

  • Mini Mental status examination (MMSE) score below 25

  • Significant sensory deficits, e.g., hearing or sight impairment

  • Unstable medical disorder

  • Significant postural or action tremor, moderate dyskinesia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tel Aviv University Tel Aviv Israel 6997801

Sponsors and Collaborators

  • Tel Aviv University
  • Sheba Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jason Friedman, Associate Professor, Tel Aviv University
ClinicalTrials.gov Identifier:
NCT06120192
Other Study ID Numbers:
  • 8407-21-SMC
First Posted:
Nov 7, 2023
Last Update Posted:
Nov 7, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jason Friedman, Associate Professor, Tel Aviv University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 7, 2023